The study examined how a specific heart measurement (the slope of the end‑systolic pressure‑volume line) changes in isolated dog hearts under different conditions, but it doesn’t provide any direct advice or dosage information for people using the peptide semax or for human health optimization.

We compared transient slope of end-systolic pressure-volume line (T-Emax) with steady Emax (S-Emax) in isolated cross-circulated canine left ventricles. T-Emax is the slope of the end-systolic pressure-volume line (ESPVL) determined from the last steady-state ejecting contraction (SEC) and the first transient isovolumic contraction produced by end-diastolic volume clamp. S-Emax is the slope of ESPVL determined from five steady-state contractions by linear regression analysis. We obtained three T-Emax values in the same contractile state by changing ejection fraction (EF) of SEC to three levels (range 14-58%) from the same end-diastolic volume. T-Emax variably increased with EF in any contractile state. The ratios of the three T-Emax values to the same S-Emax value was 1.08 +/- 0.04 (11 ventricles, means +/- SE) for high EF, 0.87 +/- 0.06 for middle EF, and 0.69 +/- 0.07 for low EF in control contractile state. These ratios decreased under epinephrine and increased under propranolol. We conclude that T-Emax depends not only on EF but also on contractile state in isolated dog left ventricles.